We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC

Delisted

SGMO was delisted on the 4th of May, 2026.

156 hedge funds and large institutions have $747M invested in SANGAMO THERAPEUTICS INC in 2014 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 56 increasing their positions, 34 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,333% more call options, than puts

Call options by funds: $199M | Put options by funds: $8.16M

65% more repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 34

46% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 24

8% more funds holding

Funds holding: 145156 (+11)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

14% less capital invested

Capital invested by funds: $869M → $747M (-$122M)

Holders
156
Holders Change
+11
Holders Change %
+7.59%
% of All Funds
4.48%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.09%
New
35
Increased
56
Reduced
34
Closed
24
Calls
$199M
Puts
$8.16M
Net Calls
+$190M
Net Calls Change
-$34.2M
Name Holding Trade Value Shares
Change
Change in
Stake
LPL Financial
176
LPL Financial
California
-$189K -10,461 Closed
Verition Fund Management
177
Verition Fund Management
Connecticut
-$185K -10,228 Closed
TF
178
Trutina Financial
Washington
-$150K -8,300 Closed
IWC
179
Integrated Wealth Counsel
California
-$55K -3,065 Closed
Canada Pension Plan Investment Board
180
Canada Pension Plan Investment Board
Ontario, Canada
-$27K -1,500 Closed

SGMO Hedge Fund Activity: Q2 2014 in Review

156 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2014, worth a combined $747M — down 14% from $869M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new SGMO positions and 24 closed out — a net gain of 11 holders — while 56 added to existing stakes and 34 trimmed.

The largest buyer was Frontier Capital Management, adding an estimated $13M. The largest seller was RA Capital Management, cutting an estimated $35M.

  • 156 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2014, up from 145 in Q1 2014.
  • Funds reported $747M of SANGAMO THERAPEUTICS INC stock for Q2 2014, down 14% quarter-over-quarter.
  • 35 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2014 and 24 closed out, a net change of +11 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q2 2014 was Frontier Capital Management, an estimated $13M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q2 2014 was RA Capital Management, an estimated $35M sold.

Based on aggregated 13F filings for Q2 2014.